Suggestions

  • News
  • Careers
  • Events
  • On A High
  • Medical Cannabis Week
  • Job Listings
  • Twitter
  • Instagram
  • LinkedIn
  • Email
  • Home
  • Latest
  • Events
  • Video + Podcasts
    • BofC Live
    • Retail 2021
    • Cannabis + Technology
    • Medical Cannabis Week
    • Meet the Industry
    • On A High
    • Pitch Forward
    • MN Cannabis Conversations
    • Cannabis Forward
    • Lunch + Learn
    • Sessions
  • Insights
    • Consumer
    • Benchmark
    • Business of Cannabis
    • Perspective
  • Careers
    • Job of the Week
    • Job Listings
  • News

Mobile Logo

Browse Tag

jonathan havens

Latest/Meet the Industry/Video + Podcasts

Meet the Industry with Jonathan Havens of Saul, Ewing, Arnstein & Lehr LLP from MJBizCon 2019

January 13, 2020July 26, 2020

At #MJBizCon2019, Business of Cannabis joined MNP, MGO Ello, Aird + Berlis and the Canadian Securities Exchange inside their Canada’s Cannabis Scene booth to conduct conversations about the state of the industry. Jonathan Havens of law firm Saul, Ewing, Arnstein and Lehr LLP stopped by to talk with Jay Rosenthal of Business…

Read More
BofC Live/Latest/Video + Podcasts

US FDA Approves Epidiolex – What it Means

June 26, 2018July 11, 2020

Jonathan Havens of Saul Ewing Arnstein & Lehr LLP to talk about what the US FDA’s approval of GW Pharma’s Epidiolex CBD-derived product.  Havens described what will happen to Epidiolex now – including a possible rescheduling by the US Drug Enforcement Administration. For more about Epidolex. For more about Saul Ewing Arnstein & Lehr LLP. For more…

Latest/Meet the Industry/Video + Podcasts

Meet the Industry with Jonathan Havens of Saul, Ewing, Arnstein & Lehr LLP from MJBizCon 2019

At #MJBizCon2019, Business of Cannabis joined MNP, MGO Ello, Aird + Berlis and the Canadian Securities Exchange inside their Canada’s Cannabis Scene booth to conduct conversations about the state of the industry. Jonathan Havens of law firm…

More
January 13, 2020July 26, 2020
BofC Live/Latest/Video + Podcasts

US FDA Approves Epidiolex – What it Means

Jonathan Havens of Saul Ewing Arnstein & Lehr LLP to talk about what the US FDA’s approval of GW Pharma’s Epidiolex CBD-derived product.  Havens described what will happen to Epidiolex…

More
June 26, 2018July 11, 2020

Recent Posts

  • How to facilitate valuable brand-to-retailer-to-consumer relationships
  • The important role cannabis education plays in the cannabis sector
  • How climate can create unique craft cannabis products
  • How to use cannabis cooking for wellness
  • A look at cannabis retail store counts by Province

Categories

  • Careers
    • Job of the Week
  • Events
    • Cannabis Forward
  • Insights
    • Benchmark
    • Business of Cannabis
    • Consumer
    • Perspective
  • Latest
  • News
  • Partners
  • Video + Podcasts
    • BofC Live
    • Cannabis + Technology
    • Lunch + Learn
    • Medical Cannabis Week
    • Meet the Industry
    • MN Cannabis Conversations
    • On A High
    • Pitch Forward
    • Retail 2021
    • Sessions

Most Popular

012.7K views

Quick Hits with Pat McCutcheon, CEO, MediPharm Labs

MediPharm Labs is a Barrie, Ontario-based company focused solely on extraction. Since last we connected with MediPharm leadership, they have gone public, signed…

022.6K views

Keith Strachan, MediPharm Labs

…

032.4K views

Consolidation looms for cannabis companies

Expect more deals as business look for more ways to grow by Diane Peters Volume 1: Issue 17 It was the deal…

  • Home
  • About
  • Contact
  • Privacy
  • Terms + Conditions

© 2021 BUSINESS OF CANNABIS
ALL RIGHTS RESERVED.

  • Home
  • Latest
  • Events
  • Video + Podcasts
    • BofC Live
    • Retail 2021
    • Cannabis + Technology
    • Medical Cannabis Week
    • Meet the Industry
    • On A High
    • Pitch Forward
    • MN Cannabis Conversations
    • Cannabis Forward
    • Lunch + Learn
    • Sessions
  • Insights
    • Consumer
    • Benchmark
    • Business of Cannabis
    • Perspective
  • Careers
    • Job of the Week
    • Job Listings
  • News
  • Twitter
  • Instagram
  • LinkedIn
  • Email
Go toTop
0 £0.00